Trait Information | |
Identifier | MONDO_0100096 |
Description | A disease caused by infection with severe acute respiratory syndrome coronavirus 2. [MONDO: patterns/infectious_disease_by_agent] | Trait category |
Other disease
|
Synonyms |
16 synonyms
|
Mapped terms |
8 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS002272 (GRS6_COVID) |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
COVID-19 infection | COVID-19 | 6 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002272/ScoringFiles/PGS002272.txt.gz |
PGS002273 (GRS12_COVID) |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
COVID-19 infection | COVID-19 | 12 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS002273/ScoringFiles/PGS002273.txt.gz |
PGS004938 (pgs_data_ldpred) |
PGP000666 | Kovalenko E et al. Front Med (Lausanne) (2024) |
Severe COVID-19 course | COVID-19 | 955,503 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS004938/ScoringFiles/PGS004938.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM012926 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.38 [1.26, 1.53] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012927 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | — | OR (top 10% vs rest of population): 1.58 [1.36, 1.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012928 | PGS002272 (GRS6_COVID) |
PSS009623| African Ancestry| 2,598 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.7 [1.03, 2.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012929 | PGS002272 (GRS6_COVID) |
PSS009625| Hispanic or Latin American Ancestry| 3,752 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.56 [1.0, 2.43] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012930 | PGS002272 (GRS6_COVID) |
PSS009626| South Asian Ancestry| 760 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.42 [0.72, 2.82] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012933 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 1.39 [1.23, 1.56] | — | High clinical risk included indiviiduals with any of the following criteria: age≥65, BMI≥35, chronic kidney disease, diabetes, immunosuppressive disease, or age ≥55 and presence of chronic obstructive pulmonary disease, cardiovascular disease, or hypertension |
PPM012934 | PGS002272 (GRS6_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 1.65 [1.39, 1.96] | — | High clinical risk included indiviiduals with any of the following criteria: age≥65, BMI≥35, chronic kidney disease, diabetes, immunosuppressive disease, or age ≥55 and presence of chronic obstructive pulmonary disease, cardiovascular disease, or hypertension |
PPM012935 | PGS002272 (GRS6_COVID) |
PSS009625| Hispanic or Latin American Ancestry| 3,752 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) in those with high clinical risk | — | — | OR (top 10% vs rest of population): 3.35 [1.56, 7.2] | — | — |
PPM012936 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.659 [0.639, 0.679] | — | age, sex, PCs | — |
PPM012937 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.708 [0.688, 0.727] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
PPM012938 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.696 [0.668, 0.723] | — | age, sex, PCs | — |
PPM012939 | PGS002272 (GRS6_COVID) |
PSS009622| European Ancestry| 14,320 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.75 [0.723, 0.776] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
PPM012940 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.744 [0.731, 0.756] | — | age, sex, PCs | — |
PPM012941 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | AUROC: 0.766 [0.753, 0.778] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
PPM012942 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.796 [0.777, 0.815] | — | age, sex, PCs | — |
PPM012943 | PGS002272 (GRS6_COVID) |
PSS009621| European Ancestry| 25,353 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | AUROC: 0.814 [0.769, 0.832] | — | age, sex, PCs, BMI, CVD, hypertension, diabetes, CKD, COPD, Autoimmune | — |
PPM012931 | PGS002273 (GRS12_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of hospitalization (COVID-19) | — | — | OR (top 10% vs rest of population): 1.38 [1.26, 1.52] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM012932 | PGS002273 (GRS12_COVID) |
PSS009624| European Ancestry| 44,958 individuals |
PGP000302 | Horowitz JE et al. Nat Genet (2022) |
Reported Trait: Risk of severe disease (COVID-19) | — | — | OR (top 10% vs rest of population): 1.64 [1.43, 1.9] | Age, sex, age-by-sex interaction and ten ancestry-informative PCs | — |
PPM021730 | PGS004938 (pgs_data_ldpred) |
PSS011763| European Ancestry| 7,124 individuals |
PGP000666 | Kovalenko E et al. Front Med (Lausanne) (2024) |
Reported Trait: Severe COVID-19 course | — | AUROC: 0.6 | Odds ratio (OR, high vs low tertile): 2.25 | PC1-20, sex, gender | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS009621 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 25,353 individuals | — | European | — | AncestryDNA | — |
PSS009622 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 14,320 individuals | — | European | — | UKB | — |
PSS009623 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 2,598 individuals | — | African unspecified | — | AncestryDNA, MyCode, UKB | Meta-analysis |
PSS009624 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 44,958 individuals | — | European | — | AncestryDNA, MyCode, UKB | Meta-analysis |
PSS009625 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 3,752 individuals | — | Hispanic or Latin American | — | AncestryDNA, MyCode, UKB | Meta-analysis |
PSS009626 | COVID-19 positive, that is, those with a positive qPCR orserology test for SARS-CoV-2 or with a COVID-19-related ICD-10 code (U07), hospitalization or death | — | 760 individuals | — | South Asian | — | AncestryDNA, MyCode, UKB | Meta-analysis |
PSS011763 | Very severe respiratory confirmed covid vs. not severe respiratory confirmed covid | — | [
|
— | European | — | Genotek | — |